Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blue Jet HealthcareBOM:544009 +1.05%65 Days Inventory is 124.71 as of Jun. 2026, which is 17% below its 10-year median of 150.67. GuruFocus rates BOM:544009 with a GF Score™ of 65/100 and a GF Value™ of ₹515.12 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 637 Biotechnology companies, Blue Jet Healthcare ranks worse than 55.73% on this metric.
The historical rank and industry rank for Blue Jet Healthcare's Days Inventory or its related term are showing as below:
BOM:544009'
s Days Inventory Range Over the Past 10 Years
Min: 122.28 Med: 150.67 Max: 245.07
Current: 202.17
During the past 6 years, Blue Jet Healthcare's highest Days Inventory was 245.07. The lowest was 122.28. And the median was 150.67.
BOM:544009's Days Inventory is ranked worse than 55.73% of 637
companies
in the Biotechnology industry
Industry Median: 181.41
vs BOM:544009: 202.17
Blue Jet Healthcare's Days Inventory
declined
from Jun. 2025 (131.68) to Jun. 2026 (124.71).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Blue Jet Healthcare's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Blue Jet Healthcare's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.64.
Blue Jet Healthcare (BOM:544009) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Blue Jet Healthcare's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Blue Jet Healthcare's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Blue Jet Healthcare Days Inventory Related Terms
Blue Jet Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Blue Jet Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544009 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Blue Jet Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blue Jet Healthcare Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Blue Jet Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blue Jet Healthcare (BOM:544009) has a Days Inventory of 124.71 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Blue Jet Healthcare and its competitors. This is 17% below median its historical median of 150.67. Over the past decade, Blue Jet Healthcare's Days Inventory has ranged from 122.28 to 245.07. According to the industry distribution chart, Blue Jet Healthcare ranks #355 out of 637 companies in the Biotechnology industry, placing it in the top 55.7%.
Is Blue Jet Healthcare's Days Inventory too high?
Blue Jet Healthcare's current Days Inventory of 124.71 is 17% below median its 10-year median of 150.67. Over the past 10 years, this metric has ranged from a low of 122.28 to a high of 245.07. The Biotechnology industry median Days Inventory is 181.41. Blue Jet Healthcare's value of 124.71 is 31.3% below this industry median. Based on the distribution chart, Blue Jet Healthcare ranks #355 out of 637 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Blue Jet Healthcare has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Blue Jet Healthcare ranks #355 out of 637 companies for Days Inventory. This places Blue Jet Healthcare in the lower half of its industry. The industry median Days Inventory is 181.41. Blue Jet Healthcare's value of 124.71 is 31.3% below this benchmark. Historically, Blue Jet Healthcare's own Days Inventory has ranged from 122.28 to 245.07 over the past decade. While the company's 10-year median is 150.67 vs. the industry median of 181.41, Blue Jet Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 181.41, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blue Jet Healthcare's current Days Inventory of 124.71 is 31.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Blue Jet Healthcare and its competitors. For the Biotechnology industry, the median Days Inventory is 181.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blue Jet Healthcare's current Days Inventory is 124.71, which is 17% below median its own 10-year median of 150.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹515.12, compared to a current price of ₹593.80 — trading 15.3% above its estimated fair value. The current Days Inventory is 124.71, which is 17% below median its 10-year median of 150.67 and 31.3% below the Biotechnology industry median of 181.41. Blue Jet Healthcare's overall GF Score™ is 65/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current Days Inventory is 124.71 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?
Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued.
The current stock price of ₹593.80 is trading 15.3% above its estimated GF Value™ of ₹515.12.
GuruFocus considers Blue Jet Healthcare to be Modestly Overvalued.
Key valuation signals for BOM:544009:
Days Inventory: 124.71 (17% below median its 10-year median of 150.67)
GF Value™: ₹515.12 vs. price of ₹593.80 (15.3% above fair value)
Industry Position: 31.3% below the Biotechnology median (#355 of 637)
No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
65GF Score
Get the complete analysis for BOM:544009
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544009 has been successfully added to your 
